Liver transplantation as ultimate tool to treat portal hypertension

Digestive Diseases

Volumn 23, Issue 1, 2005, Pages 65-71

  Klupp, J ^a   Kohler, S ^a   Pascher, A ^a   Neuhaus, P ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Hepatopulmonary syndrome; Liver transplantation; Portal hypertension; Portal thrombosis; Pulmonary hypertension

Indexed keywords

ALBUMIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOSENTAN; DOPAMINE; FUROSEMIDE; ISOSORBIDE MONONITRATE; PLASMA SUBSTITUTE; PROSTACYCLIN; SPIRONOLACTONE; TERLIPRESSIN;

ASCITES; ESOPHAGUS VARICES; GASTROINTESTINAL HEMORRHAGE; HEPATIC ENCEPHALOPATHY; HEPATOPULMONARY SYNDROME; HEPATORENAL SYNDROME; HUMAN; LIVER TRANSPLANTATION; PORTAL HYPERTENSION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURVIVAL RATE; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT OUTCOME;

COMORBIDITY; HUMANS; HYPERTENSION, PORTAL; KIDNEY FAILURE, CHRONIC; LIVER TRANSPLANTATION; PATIENT SELECTION; PROGNOSIS; WAITING LISTS;

EID: 20444459053     PISSN: 02572753     EISSN: None     Source Type: Journal    
DOI: 10.1159/000084727     Document Type: Review

References (55)

1. Kapoor D, Sarin SK: Pathophysiology of portal hypertension. J Gastroenterol Hepatol 2002; 17:482-487.
2. Moreau R, Lebrec D: Endogenous factors involved in the control of arterial tone in cirrhosis. J Hepatol 1995;22:370-376.
3. Stanley AJ, Hayes PC: Portal hypertension and variceal haemorrhage. Lancet 1997;350:1235-1239.
4. Bosch J, Garcia-Pagan JC: Complications of cirrhosis. I. Portal hypertension. J Hepatol 2000;32:141-156.
5. D'Amico G, Pagliaro L, Bosch J: The treatment of portal hypertension: A meta-analytic review. Hepatology 1995;22:332-354.
6. Lata J, Hulek P, Vanasek T: Management of acute variceal bleeding. Dig Dis 2003;21:6-15.
7. Heneghan MA, Harrison PM: Pathogenesis of ascites in cirrhosis and portal hypertension. Med Sci Monit 2000;6:807-816.
8. Gentilini P, Vizzutti F, Gentilini A, La Villa G: Ascites and hepatorenal syndrome. Eur J Gastroenterol Hepatol 2001;13:313-316.
9. McCullough AJ, Mullen KD, Kalhan SC: Measurements of total body and extracellular water in cirrhotic patients with and without ascites. Hepatology 1991;14:1102-1111.
10. Arroyo V, Ginés P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, Reynolds TB, Ring-Larsen H, Scholmerich J: Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology 1996;23: 164-176.
11. Rich S: Primary pulmonary hypertension: Executive summary from the World Symposium on Primary Pulmonary Hypertension 1998. Geneva, World Health Organization 1998.
12. Hoepper MM, Krowka MJ, Strassburg CP: Portopulmonary hypertension and hepatopulmonary syndrome. Lancet 2004;363:1461-1468.
13. Bosch J, Abraldes JG, Groszmann P: Current management of portal hypertension. J Hepatol 2003;38:S54-S68.
14. Wiest R, Groszmann R: Nitric oxide and portal hypertension: Its role in the regulation of intrahepatic and splanchnic vascular resistance. Semin Liver Dis 1999;19:411-426.
15. Boyer TD: Pharmacologic treatment of portal hypertension: Past, present, and future. Hepatology 2001;34:834-839.
16. Burroughs AK, Patch DW: Management of variceal haemorrhage in cirrhotic patients. Gut 2001;48:738-740.
17. Ginés P, Fernandez-Esparrach G, Monescillo A, Vila C, Domenech E, Abecasis R, Angeli P, Ruiz-Del-Arbol L, Planas R, Sola R, Gines P, Terg R, Inglada L, Vaque P, Salerno F, Vargas V, Clemente G, Quer JC, Jimenez W, Arroyo V, Rodes J: Randomized trial comparing albumin, dextran 70, polygeline in cirrhotic patients with ascites treated with paracentesis. Gastroenterology 1996;111:1002-1010.
18. Richter GM, Noeldge G, Palmaz JC, Roessle M, Slegerstetter V, Franke M, Gerok W, Wenz W, Farthman E: Transjugular intrahepatic portacaval stent shunt: Preliminary clinical results. Radiology 1990;174:1027-1030.
19. Roessle M, Grandt D: TIPS: An update. Best Prac Res Clin Gastroenterol 2004;18:99-123.
20. Lasch HM, Fried MW, Zacks SL, Odell P, Johnson MW, Gerber DA, Sandhu FS, Fair JH, Shrestha R: Use of transjugular intrahepatic portosystemic shunt as a bridge to liver transplantation in a patient with severe hepatopulmonary syndrome. Liver Transpl 2001;7: 147-149.
21. Glanemann M, Mueller AR, Stange B, Steinmueller T, Neuhaus P: Orthotopic liver transplantation in case of TIPS stent dislocation. Zentralbl Chir 2002;127:997-1000.
22. Millis JM, Martin P, Gomes A, Shaked A, Colquhoun SD, Jurim O, Goldstein L, Busuttil RW: Transjugular intrahepatic portosystemic shunts: Impact on liver transplantation. Liver Transpl Surg 1995;1:229-233.
23. Otto G, Datsis K, Richter G, Senninger N, Theilmann L, Herfarth C: Liver transplantation after sugical shunt or transjugular intrahepatic portosystemic shunt. Radiologe 1994;34: 187-190.
24. Stipa S, Balducci G, Ziparo V, Stipa F, Lucandri G: Total shunting and elective management of variceal bleeding. World J Surg 1994; 18:200-204.
25. Bismuth H, Franco D, Hepp J: Portal-systemic shunt in hepatic cirrhosis: Does the type of shunt decisively influence the clinical result? Ann Surg 1974;179:209-218.
26. Sarfeh IJ, Rypins EB, Mason GR: A systemic appraisal of portocaval H-graft diameters. Clinical and hemodynamic perspectives. Ann Surg 1986;204:356-363.
27. Warren WD, Zeppa R, Fomon JJ: Selective trans-splenic decompression of gastroesophageal varices by distal splenorenal shunt. Ann Surg 1967;166:437-455.
28. Henderson JM: Surgical treatment of portal hypertension. Baillieres Best Pract Res Clin Gastroenterol 2000;14:911-925.
29. Rikkers LF, Jin G, Langnas AN, Shaw BW Jr: Shunt surgery during the era of liver transplantation. Ann Surg 1997;226:51-57.
30. Mazzaferro V, Rodo S, Tzakis AG, Stieber AC, Makowka L, Starzl TE: Liver transplantation in patients with previous portasystemic shunt. Am J Surg 1990;160:111-116.
31. Wood RP, Shaw BW, Rikkers LF: Liver transplantation for variceal hemorrhage. Surg Clin North Am 1990;70:449-461.
32. Orozco H, Mercado MA, Takahashi T, Hernandez-Ortiz J, Capellan JF, Garcia-Tsao G: Elective treatment of bleeding varices with a Sugiura operation over 10 years. Am J Surg 1992;163:585-589.
33. Gonwa TA, Klintmalm GB, Levy M, Jennings LS, Goldstein RM, Husberg BS: Impact of pretransplant renal function on survival after liver transplantation. Transplantation 1995; 59: 361-365.
34. Schott R, Chaouat A, Launoy A, Pottecher T, Weitzenblum E: Improvement of pulmonary hypertension after liver transplantation. Chest 1999;115:1748-1749.
35. Iwatsuki S, Starzl TE, Todo D, Gordon RD, Tzakis AG, Marsh JW, Makowka L, Koneru B, Stieber A, Klintmalm G, et al: Liver transplantation in the treatment of bleeding esophageal varices. Surgery 1988;104:697-705.
36. Henderson JM: Liver transplantation for portal hypertension. Gastroenterol Clin North Am 1992;21:192-213.
37. Brown RS Jr, Kumar KS, Russo MW, Kinkhabwala M, Rudow DL, Harren P, Lobritto S, Emond JC: Model for end-stage liver disease and Child-Turcotte-Pugh score as predictors of pretransplantation disease severity, posttransplantation outcome, and resource utilization in United Network for Organ Sharing status 2A patients. Liver Transpl 2002;8:278-284.
38. Freeman RB, Wiesner RH, Roberts JP, McDiarmid S, Dykstra DM, Merian RM: Improving liver allocation: MELD and PELD. Am J Transpl 2004;4:114-131.
39. Wiesner R, Edwards E, Freeman R, Harper A, Kim R, Kamath P, Kremers W, Lake J, Howard T, Merion RM, Wolfe RA, Krom R, et al: Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology 2003;124:91-96.
40. Starkel P, Vera A, Gunson B, Mutimer D: Outcome of liver transplantation for patients with pulmonary hypertension. Liver Transpl 2002; 8:382-388.
41. Gonwa TA, Mai ML, Melton LB, Hays SR, Goldstein RM, Levy MF, Klintmalm GB: End-stage renal disease (ESRD) after orthotopic liver transplantation (OLTX) using calcineurin-based immunotherapy. Transplantation 2001;72:1934-1939.
42. Flechner SM: Minimizing calcineurin inhibitor drugs in renal transplantation. Transplant Proc 2003;35:118-121.
43. Troisi R, Praet M, de Hemptinne B: Small-for-size syndrome: What is the problem? Liver Transpl 2003;9:1.
44. Sato Y, Yamamoto S, Oya H, Nakatsuka H, Tsukahara A, Kobayashi T, Watanabe T, Hatakeyama K: Splenectomy for reduction of excessive portal hypertension after adult living-related donor liver transplantation. Hepatogastoenterology 2002;49:1652-1655.
45. Kiuchi T, Kasahara M, Uryuhara K, Inomata Y, Uemoto S, Asonuma K, Egawa H, Fujita S, Hayashi M, Tanaka K: Impact of graft size mismatching on graft prognosis in liver transplantation from living donors. Transplantation 1999;67:312-327.
46. Hirata M, Kita Y, Harihra Y, Hisatomi S, Sano K, Mizuta K, Yoshino H, Sugawara Y, Takayama T, Kawarasaki H, Hashizume K, Makuuchi M: Gastrointestinal bleeding after living-related liver transplantation. Dig Dis Sci 2002; 47:2386-2388.
47. Troisi R, de Hemptinne B: Clinical relevance of adapting portal vein flow in living donor liver transplantation in adult patients. Liver Transpl 2003;9:36-41.
48. Garcia-Valdecasas JC, Fuster J, Charco R, Bombuy E, Fondevila C, Ferrer J, Ayuso C, Taura P: Changes in portal vein flow after adult living-donor liver transplantation: Does it influence postoperative liver function? Liver Transpl 2003;9: 564-569.
49. Ito T, Kiuchi T, Yamamoto H, Oike F, Ogura Y, Fujimoto Y, Hirohashi K, Tanaka K: Changes in portal venous pressure in the early phase after living-donor liver transplantation: Pathogenesis and clinical implications. Transplantation 2003;75:1313-1317.
50. Troisi R, Cammu G, Militerno G, de Baerdemaeker L, Decruyenaere J, Hoste E, Smeets P, Colle I, van Vlierberghe H, Petrovic M, Voet D, Mortier E, Hesse UJ, de Hemptinne B: Modulation of portal graft inflow: A necessity in adult living-donor liver transplantation? Ann Surg 2003;237:429-436.
51. Molmenti EP, Roodhouse TW, Molmenti H, Jaiswal K, Jung G, Marubashi S, Sanchez EQ, Gogel B, Levy MF, Goldstein RM, Fasola CG, Elliott EE, Bursac N, Mulligan D, Gonwa TA, Klintmalm GB: Thrombendvenectomy for organized portal vein thrombosis at the time of liver transplantation. Ann Surg 2002;235:292-296.
52. Cherqui D, Duvoux C, Rahmouni A, Rotman N, Dhumeaux D, Julien M, Fagniez PL: Orthotopic liver transplantation in the presence of partial or total portal vein thrombosis: Problems in diagnosis and management. World J Surg 1993;17:669-674.
53. Ott R, Boehner C, Mueller S, Aigner T, Bussenius-Kammerer M, Yedibela S, Kissler H, Hohenberger W, Reck T, Mueller V: Outcome of patients with pre-existing portal vein thrombosis undergoing arterialization of the portal vein during liver transplantation. Trans Int 2003;16:15-20.
54. Stange B, Glanemann M, Nuessler NC, Bechstein WO, Neuhaus P, Settmacher U: Indication, technique, and outcome of portal vein arterialization in orthotopic liver transplantation. Transplant Proc 2001;33:1414-1415.
55. Kadry Z, Selzner N, Handschin A, Muellhaupt B, Renner EL, Clavien PA: Living donor liver transplantation in patients with portal vein thrombosis: A survey and review of technical issues. Transplantation 2002;74:696-701.